ArticleHeliyon2023

Effectiveness and safety of first-line immune checkpoint inhibitors for patients with extensive-stage small cell lung carcinoma: A systematic review and network meta-analysis.

Jincheng Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.